You have 9 free searches left this month | to do more

Parsaclisib

Parsaclisib is a drug used to treat Lymphoma, Advanced Malignancies, B-Cell Malignancies, and other conditions. Parsaclisib is being actively studied in 20 studies and prior, has been studied in 5.

Top SponsorsTop SitesTop Investigators
Incyte CorporationHospital Universitario Virgen Del RocioJohn Reneau
Incyte Biosciences Japan GKHospital Clinico Universitario de SalamancaJunning Cao, MD
Fudan UniversityTel Aviv Sourasky Medical CenterYanyan Liu
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
2022-02-10
Feb 10, 2022
H
Not yet recruiting
  • Peripheral T-Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-12-26
Dec 26, 2021
I
Not yet recruiting
  • Follicular Lymphoma ( FL)
  • Marginal Zone Lymphoma (MZL)
  • parsaclisib
  • +2 more
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-10-07
Oct 7, 2021
I
Recruiting
  • B-Cell Malignancies
  • Parsaclisib
  • +3 more
  • Birmingham, Alabama
  • +28 more
2022-03-30
Mar 30, 2022
U
Withdrawn
  • Breast Cancer
  • +3 more
  • Parsaclisib
  • (no location specified)
2020-11-02
Nov 2, 2020
I
Active, not recruiting
  • Advanced Malignancies
  • parsaclisib
  • Tustin, California
  • +3 more
2022-03-14
Mar 14, 2022
I
I
Not yet recruiting
  • Mantle Cell Lymphoma
  • parsaclisib
  • +3 more
  • (no location specified)
2022-02-14
Feb 14, 2022
I
Active, not recruiting
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +38 more
2022-04-05
Apr 5, 2022
I
Completed
  • Primary Sjögren's Syndrome
  • Parsaclisib
  • Miami, Florida
  • +3 more
2021-08-11
Aug 11, 2021
I
Active, not recruiting
  • Lymphoma
  • Parsaclisib
  • Aichi, Japan
  • +5 more
2022-01-24
Jan 24, 2022
I
Recruiting
  • Non Hodgkins Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Aichi, Japan
  • +4 more
2022-01-24
Jan 24, 2022
M
Recruiting
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • +13 more
  • Scottsdale, Arizona
  • +2 more
2021-08-19
Aug 19, 2021
I
Active, not recruiting
  • Autoimmune Hemolytic Anemia
  • Parsaclisib
  • Washington, District of Columbia
  • +12 more
2021-12-14
Dec 14, 2021
I
Withdrawn
  • Pemphigus Vulgaris
  • Parsaclisib
  • (no location specified)
2019-09-11
Sep 11, 2019
I
Active, not recruiting
  • B-cell Lymphoma
  • Parsaclisib
  • +3 more
  • Tucson, Arizona
  • +20 more
2022-03-29
Mar 29, 2022
I
Recruiting
  • Myelofibrosis
  • +3 more
  • parsaclisib
  • +2 more
  • Anchorage, Alaska
  • +155 more
2022-04-06
Apr 6, 2022
I
Active, not recruiting
  • Lymphoma
  • Parsaclisib
  • Phoenix, Arizona
  • +82 more
2022-01-14
Jan 14, 2022